Ancient herbal paste put to the test against heart disease chest pain

NCT ID NCT07478328

Not yet recruiting Symptom relief Sponsor: Longhua Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tests whether a traditional Chinese herbal paste called Chaigui Longmu Ejiao Paste can reduce weekly angina attacks in people with ischemic heart disease. Sixty adults aged 18-75 who have stable angina and are on standard heart medications will take the paste or a placebo twice daily for 8 weeks. The study measures changes in angina frequency and heart-related quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Chaigui Longmu Ejiao Paste (a traditional Chinese herbal paste)
What this could lead to: If it works, this could provide a new option to reduce chest pain episodes in people with heart disease.
What could go wrong: This is a small, early-phase trial with only 60 participants, so results may not apply broadly. The placebo also contains herbs, making it hard to know if the active ingredient is truly effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC HEART DISEASE

Contacts and locations

Locations

Longhua Hospital Shanghai University of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, Xuhui District, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.